Infect Disord Drug Targets
. 2023 Mar 24.
doi: 10.2174/1871526523666230324113146. Online ahead of print.
SARSCoV2 Omicron (B. 1.1. 529) recent updates and challenges worldwide
Rina Das 1 , Sherril Yadav 1 , Vishal Sharma 1 , Sumeet Gupta 1 , Anju Goyal 2 , Dinesh Kumar Mehta 1
Affiliations
- PMID: 36967463
- DOI: 10.2174/1871526523666230324113146
Abstract
The current world is plagued by unpredictability as a result of various COVID-19 variants. The current variants of concern (VOCs) are B.1.1.7 (Alpha), B.1.351 (Beta), P.1 (Gamma) and B.1.617/B.1.617.2(Delta). WHO classified two variants, delta (B.1.617.2) and omicron (B.1.1.529), as having highly mutable strikes. The WHO predicted that it would be more dangerous than previous variants due to its mutatable capability. The Omicron variant of coronavirus has caused widespread disruption, with countries struggling to manage the massive number of infections. Due to its unique properties, such as protein structure, symptoms, transmission, and epidemiology, this review aims to compare omicron to other variants. Furthermore, we have highlighted vaccines that have been used to combat this pandemic.
Keywords: COVID-19; Mutation; Omicron; Spreadability; VOCs; Vaccine.